Mr John Gillen
European Nad Pioneer, Managing Director

For over a decade he has travelled the world to obtain answers. This led to the realisation that the co-enzyme NAD+ Nicotinamide adenine dinucleotide, was the central metabolite required for cell function. John explains it quite simply as being the "miracle molecule", finding scientific evidence for this cellular fuel, realising the potential for numerous conditions from Alcohol Detox to NAD+ as the vital component for regenerative medicine. John was the first pioneer to bring NAD+ treatment to Europe in 2010 Johns' passion extends to other metabolic disturbances and neurodegenerative diseases.

The journey continues, in recent times John has travelled to Russia to study and research into a new therapy photobiomudulation or systemic laser therapy working with NAD+ scientists and the very best of the medical profession in the UK and the USA. Together with Nadcell, Doctors, nurses, dieticians and therapists – Johns's passion continues to endeavour to bring further research to the UK and Europe, with new developments in NAD+ therapy in preventive and restorative medicine and Wellness.

In 2017 John Gillen was made a visiting Professor at the John Naisbitt university in Belgrade Serbia.

John Gillen is not a doctor or clinician. Any health information relayed via email or any other medium is not intended to diagnose, treat or cure an illness.